Desensitization in Iron Product Allergy
- PMID: 32182610
- DOI: 10.1159/000503768
Desensitization in Iron Product Allergy
Abstract
Iron deficiency is the main cause of anemia in both sexes, with women being more commonly affected. Iron therapy is currently considered an effective and safe remedy to replenish the iron storages. Iron can be administrated both orally and intravenously. In particular, intravenous (IV) iron therapy is widely used when oral iron preparations are either not tolerated or ineffective. Indeed, IV iron improves iron stores more rapidly. Two main immunological responses have been described for iron hypersensitivity reactions (HSRs): IgE-mediated allergy and complement activation-related pseudo-allergy. Here, we report 3 cases of adult patients with iron allergy, who were successfully treated with two different desensitization procedures, respectively. Analysis of these cases demonstrates that, in the presence of HSRs to iron products, desensitization is an effective and safe procedure that prevents treatment discontinuation and hence allows therapeutic target achievement.
Keywords: Drug allergy; Drug desensitization; Oral desensitization; Precision medicine in allergy; Rapid desensitization protocol.
© 2020 S. Karger AG, Basel.
Similar articles
-
One-Bag 8-Step Ferric Carboxymaltose Desensitization Protocol for Patients with a History of Hypersensitivity Reactions to Iron Preparations.Int Arch Allergy Immunol. 2024;185(5):449-455. doi: 10.1159/000535785. Epub 2024 Jan 25. Int Arch Allergy Immunol. 2024. PMID: 38272014
-
A Safe and Novel Desensitization Protocol with Ferric Carboxymaltose to Treat Iron Deficiency Anemia.Curr Drug Saf. 2016;11(2):145-8. doi: 10.2174/1574886311666151209114203. Curr Drug Saf. 2016. PMID: 26647917
-
Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.Am J Nephrol. 2017;45(1):49-59. doi: 10.1159/000451060. Epub 2016 Nov 26. Am J Nephrol. 2017. PMID: 27889746
-
[Iron supplementation in chronic kidney disease].Wiad Lek. 2017;70(6 pt 2):1215-1218. Wiad Lek. 2017. PMID: 29533917 Review. Polish.
-
Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.Br J Pharmacol. 2015 Nov;172(21):5025-36. doi: 10.1111/bph.13268. Epub 2015 Oct 25. Br J Pharmacol. 2015. PMID: 26265306 Free PMC article. Review.
Cited by
-
The experiences of ferric carboxymaltose desensitization and provocation.World Allergy Organ J. 2025 Jan 17;18(2):101025. doi: 10.1016/j.waojou.2024.101025. eCollection 2025 Feb. World Allergy Organ J. 2025. PMID: 39902113 Free PMC article.
-
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS).Orphanet J Rare Dis. 2022 Nov 3;17(1):402. doi: 10.1186/s13023-022-02556-7. Orphanet J Rare Dis. 2022. PMID: 36329518 Free PMC article.
-
Hypersensitivity to Intravenous Iron Preparations.Children (Basel). 2022 Sep 27;9(10):1473. doi: 10.3390/children9101473. Children (Basel). 2022. PMID: 36291409 Free PMC article. Review.
-
Rapid desensitization for human serum albumin (Grifols®) hypersensitivity.Postepy Dermatol Alergol. 2024 Dec;41(6):634-636. doi: 10.5114/ada.2024.145434. Epub 2024 Nov 27. Postepy Dermatol Alergol. 2024. PMID: 39877104 Free PMC article. No abstract available.
-
Knowledge mapping and global trends of drug hypersensitivity from 2013 to 2023: A bibliometric analysis.Immun Inflamm Dis. 2024 Apr;12(4):e1245. doi: 10.1002/iid3.1245. Immun Inflamm Dis. 2024. PMID: 38629759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical